50至70岁患者外科主动脉瓣置换中机械瓣与生物瓣的长期结局比较
该回顾性队列研究纳入芬兰2004至2014年首次SAVR的50-70岁患者2928例,经倾向评分匹配1152例,比较机械瓣与生物瓣10年结局。结果显示机械瓣全因死亡率、再手术率和感染性心内膜炎发生率更低,但大出血和缺血性卒中无显著差异。
要点
- 机械瓣10年全因死亡率低于生物瓣(18.6% vs 27.6%,HR 0.72)。
- 机械瓣再手术率低于生物瓣(1.4% vs 8.5%,HR 0.30)。
- 机械瓣感染性心内膜炎发生率低于生物瓣(3.7% vs 7.3%,HR 0.46)。
核心结论
- 在50至70岁匹配患者中,机械瓣较生物瓣10年内全因死亡率、再手术率和感染性心内膜炎发生率更低。
- 结果不支持该年龄段常规使用生物瓣。
研究设计与样本
- 芬兰2004至2014年首次SAVR的50至70岁患者回顾性研究,排除感染性心内膜炎及除CABG外的合并手术,N=2928。
- 采用1:1倾向评分匹配获得基线可比的1152例患者,平均随访6.7年。
临床怎么用
- 对于50至70岁首次SAVR且无感染性心内膜炎及合并手术的患者,机械瓣可能带来更低的10年死亡、再手术和心内膜炎风险。
- 决策时需结合患者出血风险与抗凝意愿个体化评估。
局限性
- 回顾性研究设计。
- 原文未报告其他局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The use of biologic prosthesis is increasing in surgical aortic valve replacement (SAVR). Recent US guidelines recommend either biologic or mechanical prosthesis for SAVR in patients aged 50 to 70 years. We set out to study long-term outcomes of mechanical versus biologic prosthetic valves in this patient group. METHODS: All patients (excluding infective endocarditis and concomitant surgery other than coronary artery bypass grafting) aged 50 to 70 with first-time SAVR in Finland between 2004 and 2014 were retrospectively studied (N = 2928). Propensity score matching (1:1) was used to identify patients with comparable baseline features (n = 1152). Outcomes were 10-year all-cause mortality, aortic valve reoperation, major bleeding, ischemic stroke, and infective endocarditis. Mean follow-up was 6.7 years. RESULTS: Ten-year all-cause mortality was 18.6% with mechanical valves and 27.6% with biologic valves (hazard ratio [HR], 0.72; 95% confidence interval [CI], 0.54-0.97; P = .028). Prosthetic valve reoperation was performed in 1.4% with mechanical valves and in 8.5% with bioprosthetic valves (HR, 0.30; 95% CI, 0.12-0.74; P = .009). Major bleeding occurred in 21.5% with mechanical valves and in 16.9% with biologic prostheses (HR, 1.19; P = .402). Rates of intracranial bleeding were also comparable. Ischemic stroke rates within 10 years were 12.7% with mechanical valves and 9.3% with biologic valves (HR, 1.29; P = .316). Infective endocarditis occurred in 3.7% of mechanical valves and in 7.3% of biologic valves (HR, 0.46; 95% CI, 0.24-0.88; P = .018). CONCLUSIONS: Mechanical valve prostheses were associated with lower mortality, lower rates of reoperation, and lower occurrence of infective endocarditis compared with bioprostheses within 10 years after SAVR in matched patients aged 50 to 70 years. Our results do not support the routine use of biologic valve prostheses in this patient group.
引用
- Kytö V, Sipilä J, Ahtela E, et al. Mechanical Versus Biologic Prostheses for Surgical Aortic Valve Replacement in Patients Aged 50 to 70. Ann Thorac Surg. 2019. PMID: 31786289. doi:10.1016/j.athoracsur.2019.10.027
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。